blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1490338

EP1490338 - USE OF AN ALFA2-ADRENORECEPTOR ANTAGONIST FOR CNS-RELATED DISEASES [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  29.06.2012
Database last updated on 22.01.2025
Most recent event   Tooltip18.07.2014Lapse of the patent in a contracting state
New state(s): HU		published on 20.08.2014  [2014/34]
Applicant(s)For all designated states
ORION CORPORATION
Orionintie 1
02200 Espoo / FI
[2007/16]
Former [2005/44]For all designated states
ORION CORPORATION
Orionintie 1
02200 Espoo / FI
Former [2005/01]For all designated states
ORION CORPORATION
Orionintie 1
02200 Espoo / FI
For all designated states
Oy Juvantia Pharma Ltd
Lemminkäisenkatu 5
20520 Turku / FI
Inventor(s)01 / SALLINEN, Jukka
Puutarhakatu 24 C 32
FIN-20100 Turku / FI
02 / SIRVIÖ, Jouni
Hiirihaukantie 23
FIN-70820 Kuopio / FI
 [2005/01]
Representative(s)Winter, Brandl - Partnerschaft mbB
Alois-Steinecker-Straße 22
85354 Freising / DE
[N/P]
Former [2006/06]Winter, Brandl, Fürniss, Hübner Röss, Kaiser, Polte Partnerschaft Patent- und Rechtsanwaltskanzlei
Alois-Steinecker-Strasse 22
85354 Freising / DE
Former [2005/01]Svensson, Johan Henrik
Berggren Oy Ab, P.O. Box 16
00101 Helsinki / FI
Application number, filing date03714995.203.04.2003
[2005/01]
WO2003FI00254
Priority number, dateUS20020369323P03.04.2002         Original published format: US 369323 P
[2005/01]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO03082825
Date:09.10.2003
Language:EN
[2003/41]
Type: A1 Application with search report 
No.:EP1490338
Date:29.12.2004
Language:EN
The application published by WIPO in one of the EPO official languages on 09.10.2003 takes the place of the publication of the European patent application.
[2004/53]
Type: B1 Patent specification 
No.:EP1490338
Date:24.08.2011
Language:EN
[2011/34]
Search report(s)International search report - published on:EP09.10.2003
ClassificationIPC:C07D215/00, C07D239/00, C07D491/00, A61K31/435, A61P25/16
[2005/01]
CPC:
C07D295/073 (EP,US); A61K31/435 (EP,US); A61P25/08 (EP);
A61P25/14 (EP); A61P25/16 (EP); A61P25/18 (EP);
A61P25/24 (EP); A61P25/28 (EP); A61P25/30 (EP);
A61P25/32 (EP); A61P25/34 (EP); A61P27/02 (EP);
A61P43/00 (EP); A61P5/24 (EP) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   RO,   SE,   SI,   SK,   TR [2005/01]
Extension statesAL13.09.2004
LT13.09.2004
LV13.09.2004
MK13.09.2004
TitleGerman:VERWENDUNG EINES ALFA2-ADRENOREZEPTORANTAGONISTEN BEI MIT DEM ZNS ZUSAMMENHÄNGENDEN ERKRANKUNGEN[2005/01]
English:USE OF AN ALFA2-ADRENORECEPTOR ANTAGONIST FOR CNS-RELATED DISEASES[2005/01]
French:UTILISATION DE L'ANTAGONISTE D'UN ALFA2-ADRENOCEPTEUR EN CAS DE MALADIES DU SNC[2005/01]
Entry into regional phase13.09.2004National basic fee paid 
13.09.2004Designation fee(s) paid 
13.09.2004Examination fee paid 
Examination procedure30.10.2003Request for preliminary examination filed
International Preliminary Examining Authority: EP
13.09.2004Examination requested  [2004/53]
07.02.2008Despatch of a communication from the examining division (Time limit: M06)
17.07.2008Reply to a communication from the examining division
25.03.2009Despatch of a communication from the examining division (Time limit: M07)
02.11.2009Reply to a communication from the examining division
23.11.2009Despatch of a communication from the examining division (Time limit: M06)
01.06.2010Reply to a communication from the examining division
01.07.2010Despatch of a communication from the examining division (Time limit: M04)
05.11.2010Reply to a communication from the examining division
25.02.2011Communication of intention to grant the patent
04.07.2011Fee for grant paid
04.07.2011Fee for publishing/printing paid
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  07.02.2008
Opposition(s)25.05.2012No opposition filed within time limit [2012/31]
Fees paidRenewal fee
23.04.2005Renewal fee patent year 03
13.07.2006Renewal fee patent year 04
26.04.2007Renewal fee patent year 05
27.03.2008Renewal fee patent year 06
29.04.2009Renewal fee patent year 07
19.03.2010Renewal fee patent year 08
11.04.2011Renewal fee patent year 09
Penalty fee
Additional fee for renewal fee
30.04.200604   M06   Fee paid on   13.07.2006
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU03.04.2003
AT24.08.2011
BE24.08.2011
CY24.08.2011
CZ24.08.2011
DK24.08.2011
EE24.08.2011
FI24.08.2011
NL24.08.2011
RO24.08.2011
SE24.08.2011
SI24.08.2011
SK24.08.2011
TR24.08.2011
BG24.11.2011
GR25.11.2011
PT26.12.2011
IE03.04.2012
LU03.04.2012
CH30.04.2012
LI30.04.2012
MC30.04.2012
[2014/34]
Former [2014/27]AT24.08.2011
BE24.08.2011
CY24.08.2011
CZ24.08.2011
DK24.08.2011
EE24.08.2011
FI24.08.2011
NL24.08.2011
RO24.08.2011
SE24.08.2011
SI24.08.2011
SK24.08.2011
TR24.08.2011
BG24.11.2011
GR25.11.2011
PT26.12.2011
IE03.04.2012
LU03.04.2012
CH30.04.2012
LI30.04.2012
MC30.04.2012
Former [2014/21]AT24.08.2011
BE24.08.2011
CY24.08.2011
CZ24.08.2011
DK24.08.2011
EE24.08.2011
FI24.08.2011
NL24.08.2011
RO24.08.2011
SE24.08.2011
SI24.08.2011
SK24.08.2011
TR24.08.2011
BG24.11.2011
GR25.11.2011
PT26.12.2011
IE03.04.2012
CH30.04.2012
LI30.04.2012
MC30.04.2012
Former [2013/29]AT24.08.2011
BE24.08.2011
CY24.08.2011
CZ24.08.2011
DK24.08.2011
EE24.08.2011
FI24.08.2011
NL24.08.2011
RO24.08.2011
SE24.08.2011
SI24.08.2011
SK24.08.2011
BG24.11.2011
GR25.11.2011
PT26.12.2011
IE03.04.2012
CH30.04.2012
LI30.04.2012
MC30.04.2012
Former [2013/08]AT24.08.2011
BE24.08.2011
CY24.08.2011
CZ24.08.2011
DK24.08.2011
EE24.08.2011
FI24.08.2011
NL24.08.2011
RO24.08.2011
SE24.08.2011
SI24.08.2011
SK24.08.2011
GR25.11.2011
PT26.12.2011
IE03.04.2012
CH30.04.2012
LI30.04.2012
MC30.04.2012
Former [2013/07]AT24.08.2011
BE24.08.2011
CY24.08.2011
CZ24.08.2011
DK24.08.2011
EE24.08.2011
FI24.08.2011
NL24.08.2011
RO24.08.2011
SE24.08.2011
SI24.08.2011
SK24.08.2011
GR25.11.2011
PT26.12.2011
CH30.04.2012
LI30.04.2012
MC30.04.2012
Former [2012/50]AT24.08.2011
BE24.08.2011
CY24.08.2011
CZ24.08.2011
DK24.08.2011
EE24.08.2011
FI24.08.2011
NL24.08.2011
RO24.08.2011
SE24.08.2011
SI24.08.2011
SK24.08.2011
GR25.11.2011
PT26.12.2011
MC30.04.2012
Former [2012/33]AT24.08.2011
BE24.08.2011
CY24.08.2011
CZ24.08.2011
DK24.08.2011
EE24.08.2011
FI24.08.2011
NL24.08.2011
RO24.08.2011
SE24.08.2011
SI24.08.2011
SK24.08.2011
GR25.11.2011
PT26.12.2011
Former [2012/23]AT24.08.2011
BE24.08.2011
CY24.08.2011
CZ24.08.2011
EE24.08.2011
FI24.08.2011
NL24.08.2011
RO24.08.2011
SE24.08.2011
SI24.08.2011
SK24.08.2011
GR25.11.2011
PT26.12.2011
Former [2012/21]AT24.08.2011
BE24.08.2011
CY24.08.2011
CZ24.08.2011
FI24.08.2011
NL24.08.2011
SE24.08.2011
SI24.08.2011
GR25.11.2011
PT26.12.2011
Former [2012/17]AT24.08.2011
BE24.08.2011
CY24.08.2011
FI24.08.2011
NL24.08.2011
SE24.08.2011
SI24.08.2011
GR25.11.2011
PT26.12.2011
Former [2012/12]AT24.08.2011
CY24.08.2011
FI24.08.2011
NL24.08.2011
SE24.08.2011
SI24.08.2011
GR25.11.2011
PT26.12.2011
Former [2012/11]AT24.08.2011
FI24.08.2011
NL24.08.2011
SE24.08.2011
SI24.08.2011
GR25.11.2011
PT26.12.2011
Former [2012/10]FI24.08.2011
NL24.08.2011
SE24.08.2011
GR25.11.2011
PT26.12.2011
Former [2012/09]FI24.08.2011
NL24.08.2011
PT26.12.2011
Former [2012/08]NL24.08.2011
Cited inInternational search[X]US4604398  (WARD TERENCE J [GB]) [X] 1-15 * column 2, line 55 *;
 [X]US4686226  (HUFF JOEL R [US], et al) [X] 1-15 * column 1, line 5 - line 60 *;
 [X]WO0037466  (JANSSEN PHARMACEUTICA NV [BE], et al) [X] 1-15 * claim 6 *;
 [X]US6156757  (KENNIS LUDO EDMOND JOSEPHINE [BE], et al) [X] 1-15 * column 1, line 10 - line 20 *;
 [X]WO0164645  (ORION CORP [FI], et al) [X] 1-15 * claim 11 *;
 [X]US6352999  (KENNIS LUDO EDMOND JOSEPHINE [BE], et al) [X] 1-15 * column 1, line 10 - line 30 *;
 [X]WO0218348  (HOFFMANN LA ROCHE [CH]) [X] 1-15 * page 3, line 13 - line 14 *;
 [PA]US2002045614  (BECKER CYRUS KEPHRA [US], et al) [PA] 1-15* claims 1-32 *;
 [PX]US6426350  (KENNIS LUDO EDMOND JOSEPHINE [BE], et al) [PX] 1-15 * column 1, line 5 - line 30 *;
 [PX]US6495555  (KENNIS LUDO EDMOND JOSEPHINE [BE], et al) [PX] 1-15 * column 1, line 10 - line 25 *
by applicant   - SWERDLOW, N. R. ET AL., THE ARCHIVES OF GENERAL PSYCHIATRY, (1994), vol. 51, pages 139 - 154
    - MACDONALD. E. ET AL., TRENDS PHARMACOL. SCI., (1997), vol. 18, pages 211 - 219
    - SCHEININ, M. ET AL., LIFE SCI, (2001), vol. 68, no. 19-20, pages 2277 - 85
    - SALLINEN, J. ET AL., J. NEUROSCI., (1998), vol. 18, pages 3035 - 42
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.